SKI Market

Indian Indices

Sensex

83,580.40 266.47
( 0.32%)

Global Indices

Nasdaq

50,145.69 1,215.96
(2.49%)

Dow Jones

6,954.50 135.10
(1.98%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,359.93 50.71
(0.49%)

Forex

USD-INR

90.32 -0.07
(-0.08%)

EUR-INR

106.52 -0.28
(-0.26%)

GBP-INR

122.68 -1.05
(-0.85%)

JPY-INR

0.58 0.00
(-0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.2

774.21

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

Cupid consolidated net profit rises 196.30% in the December 2025 quarter

Jan 30,2026

Net profit of Cupid rose 196.30% to Rs 32.83 crore in the quarter ended December 2025 as against Rs 11.08 crore during the previous quarter ended December 2024. Sales rose 101.73% to Rs 93.50 crore in the quarter ended December 2025 as against Rs 46.35 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	93.50	46.35	102
OPM %	36.68	24.55	-
PBDT	44.58	15.39	190
PBT	43.27	14.10	207
NP	32.83	11.08	196

83,580.40 266.47 ( 0.32%)

50,145.69 1,215.96 (2.49%)

6,954.50 135.10 (1.98%)

54,176.23 358.19 (0.67%)

10,359.93 50.71 (0.49%)

90.32 -0.07 (-0.08%)

106.52 -0.28 (-0.26%)

122.68 -1.05 (-0.85%)

0.58 0.00 (-0.33%)